Performance of statistical methods for analysing survival data in the presence of non-random compliance
- PMID: 20963732
- DOI: 10.1002/sim.4070
Performance of statistical methods for analysing survival data in the presence of non-random compliance
Abstract
Noncompliance often complicates estimation of treatment efficacy from randomized trials. Under random noncompliance, per protocol analyses or even simple regression adjustments for noncompliance, could be adequate for causal inference, but special methods are needed when noncompliance is related to risk. For survival data, Robins and Tsiatis introduced the semi-parametric structural Causal Accelerated Life Model (CALM) which allows time-dependent departures from randomized treatment in either arm and relates each observed event time to a potential event time that would have been observed if the control treatment had been given throughout the trial. Alternatively, Loeys and Goetghebeur developed a structural Proportional Hazards (C-Prophet) model for when there is all-or-nothing noncompliance in the treatment arm only. Whitebiet al. proposed a 'complier average causal effect' method for Proportional Hazards estimation which allows time-dependent departures from randomized treatment in the active arm. A time-invariant version of this estimator (CHARM) consists of a simple adjustment to the Intention-to-Treat hazard ratio estimate. We used simulation studies mimicking a randomized controlled trial of active treatment versus control with censored time-to-event data, and under both random and non-random time-dependent noncompliance, to evaluate performance of these methods in terms of 95 per cent confidence interval coverage, bias and root mean square errors (RMSE). All methods performed well in terms of bias, even the C-Prophet used after treating time-varying compliance as all-or-nothing. Coverage of the latter method, as implemented in Stata, was too low. The CALM method performed best in terms of bias and coverage but had the largest RMSE.
Copyright © 2010 John Wiley & Sons, Ltd.
Similar articles
-
Using the instrumental variables estimator to analyze noninferiority trials with noncompliance.J Biopharm Stat. 2010 Jul;20(4):745-58. doi: 10.1080/10543401003618157. J Biopharm Stat. 2010. PMID: 20496203
-
Estimation of treatment effect adjusting for treatment changes using the intensity score method: application to a large primary prevention study for coronary events (MEGA study).Stat Med. 2008 May 10;27(10):1718-33. doi: 10.1002/sim.3065. Stat Med. 2008. PMID: 17922525
-
Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.Clin Trials. 2015 Jun;12(3):265-75. doi: 10.1177/1740774515572352. Epub 2015 Mar 1. Clin Trials. 2015. PMID: 25733675 Free PMC article.
-
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep;4(3):191-206. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003. PMID: 13129806 Review.
-
Correction of confounding bias in non-randomized studies by appropriate weighting.Biom J. 2011 Mar;53(2):369-87. doi: 10.1002/bimj.201000154. Epub 2011 Feb 10. Biom J. 2011. PMID: 21308726 Review.
Cited by
-
Reducing Stress and Preventing Depression (RESPOND): Randomized Controlled Trial of Web-Based Rumination-Focused Cognitive Behavioral Therapy for High-Ruminating University Students.J Med Internet Res. 2019 May 13;21(5):e11349. doi: 10.2196/11349. J Med Internet Res. 2019. PMID: 31094331 Free PMC article. Clinical Trial.
-
Treatment crossovers in time-to-event non-inferiority randomised trials of radiotherapy in patients with breast cancer.BMJ Open. 2014 Oct 24;4(10):e006531. doi: 10.1136/bmjopen-2014-006531. BMJ Open. 2014. PMID: 25344487 Free PMC article.
-
Estimation of treatment effect in presence of noncompliance and competing risks: a simulation study.Sci Rep. 2023 Aug 18;13(1):13477. doi: 10.1038/s41598-023-40538-2. Sci Rep. 2023. PMID: 37596461 Free PMC article. Clinical Trial.
-
Methods for adjusting for bias due to crossover in oncology trials.Pharmacoeconomics. 2014 Jun;32(6):533-46. doi: 10.1007/s40273-014-0145-y. Pharmacoeconomics. 2014. PMID: 24595585
-
Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation study.BMC Med Res Methodol. 2011 Jan 11;11:4. doi: 10.1186/1471-2288-11-4. BMC Med Res Methodol. 2011. PMID: 21223539 Free PMC article.